COST-UTILITY ANALYSIS OF IMMUNE TOLERANCE INDUCTION (ITI) THERAPY VERSUS ON-DEMAND TREATMENT WITH RECOMBINANT FVII (RFVIIA) FOR HEMOPHILIA A WITH HIGH TITER INHIBITORS IN IRAN

Thumbnail Image

Files

1-s2.0-S1098301512021742-main.pdf (54.08 KB)

Date

2012

Authors

Journal Title

Journal ISSN

Volume Title

Publisher

Abstract

Description

Keywords

Citation

URI

https://dspace.tbzmed.ac.ir/handle/123456789/49539

Collections

Published Articles

Endorsement

Review

Supplemented By

Referenced By